Nutex Health (NUTX) Expected to Announce Earnings on Thursday

Key Points

• Nutex Health is set to release its Q2 2025 earnings data on Thursday, August 14th, with analysts predicting a loss of ($5.43) per share and revenue of $176.48 million.
• The company previously reported $2.56 EPS for Q1 2025, surpassing analyst estimates by $2.71, with a revenue of $211.79 million against expectations of $81.09 million.
• Brokerage firm Maxim Group raised its price target for Nutex Health from $100.00 to $225.00, while Benchmark increased theirs from $150.00 to $300.00, both maintaining a "buy" rating.

Nutex Health (NASDAQ:NUTX - Get Free Report) is anticipated to post its Q2 2025 quarterly earnings results after the market closes on Thursday, August 14th. Analysts expect Nutex Health to post earnings of ($5.43) per share and revenue of $176.48 million for the quarter.

Nutex Health (NASDAQ:NUTX - Get Free Report) last issued its earnings results on Tuesday, May 13th. The company reported $2.56 EPS for the quarter, topping the consensus estimate of ($0.15) by $2.71. The business had revenue of $211.79 million during the quarter, compared to analysts' expectations of $81.09 million. Nutex Health had a return on equity of 42.08% and a net margin of 10.76%.

Nutex Health Stock Up 1.9%

NUTX traded up $1.71 during trading on Monday, reaching $89.63. 212,218 shares of the stock traded hands, compared to its average volume of 143,951. Nutex Health has a fifty-two week low of $10.45 and a fifty-two week high of $184.27. The stock's 50-day simple moving average is $113.18 and its two-hundred day simple moving average is $99.09. The stock has a market cap of $497.89 million, a price-to-earnings ratio of 7.54 and a beta of 0.05. The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26.

Institutional Trading of Nutex Health

Several hedge funds have recently added to or reduced their stakes in the business. Bank of America Corp DE grew its holdings in shares of Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock valued at $66,000 after acquiring an additional 2,043 shares in the last quarter. Jane Street Group LLC bought a new stake in shares of Nutex Health during the first quarter worth approximately $522,000. Finally, Goldman Sachs Group Inc. boosted its holdings in shares of Nutex Health by 17.9% during the first quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company's stock worth $852,000 after acquiring an additional 2,748 shares during the period. Institutional investors and hedge funds own 5.32% of the company's stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on NUTX. Benchmark boosted their price objective on Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a research report on Thursday, May 15th. Maxim Group upped their price objective on Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research note on Tuesday, May 20th. Finally, Wall Street Zen lowered Nutex Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 22nd.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.